Open label, multinational, multicentre, prospective, real world observational study of Naloxegol for patients with cancer pain diagnosed with Opioid Induced Constipation (OIC). (NACASY) First published 16/04/2018 Last updated 06/03/2024 EU PAS number:EUPAS23610 Study Finalised